ExL Pharma's European Medical Science Liaison Conference Brochure, October, London
6
FEATURED SESSIONS INCLUDE: DEFINING AND EVALUATING THE ROLE OF THE MSL, MA AND SA Exploring Similarities and Differences in Job Titles, Descriptions and Daily Activities of Medical Science Liaisons, Medical Advisors, and Scientific Advisors across Companies and Countries Marc Van Melckenbeke, Senior Global Director Medical Communication & Coordination, Global Medical Affairs, UCB PHARMA, Belgium Dr. David Harland, Medical Scientific Liaison, UCB PHARMA, United Kingdom INVESTIGATOR INITIATED TRIALS (IITs) Outlining Best Practices for How MSLs and Advisors Can Best Support the Successful Execution of IITs across the EU Dr. Sarah Peachey, Medical Manager, PFIZER, United Kingdom KEY OPINION LEADER INITIATION AND DEVELOPMENT Effectively Managing Relationships to Meet the Needs and Objectives of the KOL and the Company Dr. Dale Kummerle, Field Medical Strategy Lead, Virology, BRISTOL-MYERS SQUIBB, France REGISTER BY 17 SEPTEMBER FOR REDUCED PRICING The Only Event Led by, and Designed for, European Pharmaceutical, Biotech and Medical Device Advisors and MSLs! CAREER DEVELOPMENT Identifying Different Opportunities Available to Individuals with MSL/Advisor Experience, Education Levels and Skills Dr. Chris Sugg, Senior Regional Medical Liaison, AMGEN GLOBAL ONCOLOGY SCIENTIFIC AFFAIRS, United States Bringing Maximum Value to the KOL, Company and Industry Medical/Scientific Advisor and Medical Science Liaison Best Practices 28-29 OCTOBER 2010, AMBASSADORS BLOOMSBURY HOTEL, LONDON PROUDLY PRESENTS To Register Call +1 212-400-6240 or visit us at www.exlpharma.com/euromsl Distinguished Speaking Faculty Joins Us From: AMGEN ARNOLD & PORTER BAYER BRISTOL-MYERS SQUIBB BRITISH PHARMACOPOEIA COMMISSION FELTER CONSULTING LTD FORMER GENENTECH GLAXOSMITHKLINE LILLY PFIZER SANOFI-AVENTIS UCB AND MORE!
-
Upload
exl-pharma -
Category
Education
-
view
2.113 -
download
0
description
Scientific Advisors (SAs), Medical Advisors (MAs) and Medical Science Liaisons (MSLs) play a critical function within Medical Affairs departments of pharmaceutical, biotech and medical device companies. These typically highly educated and experienced professionals evaluate, critique and communicate comprehensive scientific information related to a company’s products. While differences in job titles, backgrounds and day-to-day activities can vary across companies and regions, MSLs and advisors are critical to improving understanding amongst internal departments and supporting product awareness across the broader medical community. They are credible peers on whom thought leaders can rely for current, objective and thorough information about disease states and treatments. They assist clinical teams, often support and help train the sales force, and develop relationships with key opinion leaders, among other activities. MSLs/Advisors are key players in the achievement of corporate business objectives in the fiercely competitive European marketplace.ExL Pharma’s MSL Best Practices conference has a long and established history in the United States, with seven highly successful and valuable MSL events taking place throughout America over a five year period. These conferences continue to attract more and more industry professionals, and have solidified ExL Pharma as a leader in the provision of relevant and practical information for Medical Affairs professionals. From the US-based events, a need was assessed for a similar conference to take place in Europe. Thus, the European MSL & Medical/Scientific Advisor Best Practices conference was born.We are excited to offer this unique opportunity in Europe for MSLs and Advisors throughout the industry to gather to share successful strategies for both field-based and office-based activities. Through the provision of case studies and educational presentations led by experienced industry professionals, ample networking time and interactive sessions, MSLs and Advisors are sure to gain take-home approaches for providing maximum value to key opinion leaders, the company and the industry as a whole.We look forward to greeting you in London!
Transcript of ExL Pharma's European Medical Science Liaison Conference Brochure, October, London
FEATURED SESSIONS INCLUDE:DEFINING AND EVALUATING THE ROLE OF THE MSL, MA AND SAExploring Similarities and Differences in Job Titles, Descriptions and Daily Activities of Medical Science Liaisons, Medical Advisors, and Scientific Advisors across Companies and CountriesMarc Van Melckenbeke, Senior Global Director Medical Communication & Coordination, Global Medical Affairs, UCB PHARMA, Belgium Dr. David Harland, Medical Scientific Liaison, UCB PHARMA, United Kingdom
INVESTIGATOR INITIATED TRIALS (IITs)Outlining Best Practices for How MSLs and Advisors Can Best Support the Successful Execution of IITs across the EUDr. Sarah Peachey, Medical Manager, PFIZER, United Kingdom
KEY OPINION LEADER INITIATION AND DEVELOPMENTEffectively Managing Relationships to Meet the Needs and Objectives of the KOL and the CompanyDr. Dale Kummerle, Field Medical Strategy Lead, Virology, BRISTOL-MYERS SQUIBB, France
R E G I S T E R b Y 1 7 S E P T E M b E R F O R R E D U c E D P R I c I N G
The Only Event Led by, and Designed for, European Pharmaceutical, Biotech and Medical Device Advisors and MSLs!
cAREER DEVELOPMENTIdentifying Different Opportunities Available to Individuals with MSL/Advisor Experience, Education Levels and SkillsDr. Chris Sugg, Senior Regional Medical Liaison, AMGEN GLOBAL ONCOLOGY SCIENTIFIC AFFAIRS, United States
Bringing Maximum Value to the KOL, Company and Industry
Medical/Scientific Advisor and Medical Science Liaison Best Practices
28-29 OCTObER 2010, AmbASSADORS bLOOmSbURy HOTEL, LONDON
PROUDLY PRESENTS
To Register call +1 212-400-6240 or visit us at www.exlpharma.com/euromsl
Distinguished Speaking Faculty Joins Us From:
AMGENARNOLD & PORTERBAYERBRISTOL-MYERS SQUIBBBRITISH PHARMACOPOEIA COMMISSIONFELTER CONSULTING LTDFORMER GENENTECHGLAXOSMITHKLINELILLYPFIZERSANOFI-AVENTISUCBAND MORE!
Scientific Advisors (SAs), Medical Advisors (MAs) and Medical Science Liaisons (MSLs) play a critical function within Medical Affairs departments of pharmaceutical, biotech and medical device companies. These typically highly educated and experienced professionals evaluate, critique and communicate comprehensive scientific information related to a company’s products. While differences in job titles, backgrounds and day-to-day activities can vary across companies and regions, MSLs and Advisors are essential to improving understanding amongst internal departments and supporting product awareness across the broader medical community. They are credible peers on whom thought leaders can rely for current, objective and thorough information about disease states and treatments. They assist clinical teams, often support and help train the sales force, and develop relationships with key opinion leaders, among other activities. MSLs/Advisors are key players in the achievement of corporate business objectives in the fiercely competitive European marketplace.
ExL Pharma’s MSL Best Practices conference has a long and established history in the United States, with seven highly successful and valuable MSL events taking place throughout America over a five year period. These conferences continue to attract more and more industry professionals, and have solidified ExL Pharma as a leader in the provision of relevant and practical information for Medical Affairs professionals. From the US-based events, a need was assessed for a similar conference to take place in Europe. Thus, the Medical/Scientific Advisor and Medical Science Liaison Best Practices conference was born.
We are excited to offer this unique opportunity in Europe for MSLs and Advisors throughout the industry to gather to share successful strategies for both field-based and office-based activities. Through the provision of case studies and educational presentations led by experienced industry professionals, ample networking time and interactive sessions, MSLs and Advisors are sure to gain take-home approaches for providing maximum value to key opinion leaders, the company and the industry as a whole.
We look forward to greeting you in London!
Sincerely,
Lindsay Slater Kristen Hunter Conference Director Team Leader, Production European Scientific/Medical Advisor ExL Pharma and MSL Best Practices
Medical/Scientific Advisor and Medical Science Liaison Best Practices
WHo SHoUlD AttenD?
Professionals from Pharmaceutical, Biotechnology and Medical Device companies with responsibilities in the following areas:
Departments/titles• MedicalScienceLiaisons(MSLS,MLs)• MedicalAdvisors• ScientificAdvisors• MedicalManagers• MedicalScientists• MedicalAffairs• ScientificAffairs• RegionalMedicalEducationOfficers• MedicalCommunications• ClinicalTrialLiaisons• ClinicalResearch• MedicalEducation• Clinical/OutcomesLiaisons• ClinicalInvestigators• KOLDevelopment• BusinessIntelligence• RegulatoryAffairs• Marketing
this conference is also of interest to:
• SoftwareandTechnologyCompanies• StaffingAgencies/Recruiters• LawFirms• Consultants
28-29 OCTObER 2010, AmbASSADORS bLOOmSbURy HOTEL, LONDON
VENUE INFORMATION
Ambassadors Bloomsbury is a stylish, contemporary hotel, which prides itself on exceptional standards of customer service.
New rooms designed for comfort and style. Visionary conference suites. Cutting edge restaurant and bar.
Located just five minutes walk from both Euston and King’s Cross St Pancras stations (the Eurostar termi-nal), Ambassadors Bloomsbury is ideally located for both business trips and short leisure breaks.
Please contact the hotel directly at +44 (0)20 7693 5400 to book your room. Please mention ExL Pharma and the conference name to take advantage of the discount. You must book your room by 8th October 2010 to be eligible for the discounted rate. Please book your room early as the rooms available at this rate are limited and review your hotel confirmation to ensure that you received the ExL group rate.
12 Upper Woburn PlaceLondon, UKWC1H 0HXt +44 (0)20 7693 5400f +44 (0)20 7388 9930
Ambassadors Bloomsbury
Medical/Scientific Advisor and Medical Science Liaison Best Practices PRE-CONFERENCE WORKSHOP
8:00 · REGISTRATION AND BREAKFAST FOR WORKSHOP PARTICIPANTS
9:00 · PRE-CONFERENCE WORKSHOP: REGULATORY OVERVIEW
Understanding Requirements and Ensuring Compliant External and Internal Communications while Working in a Complex International EnvironmentMSLs and MAs/SAs must take great care in knowing and complying with the rules, legislation and codes of practice that are relevant to their roles, so that they do not put themselves, their companies and patients at any undue risk. They must be aware of the boundaries of their positions, especially when interacting with thought leaders in the field as well as with internal commercial teams. The regulations can be complicated to decipher and apply, and can differ significantly across countries throughout the EU. In this workshop, gain practical and relevant information on:
• Exploringsimilaritiesanddifferencesinrulesrelatedtoindustry- healthcare provider interactions within different EU nations• ExaminingthemajorregulationsandguidancethatMSLsmust follow in Europe, including an in-depth discussion of the ABPI Code of Practice for the Pharmaceutical Industry in the UK• Compliantlycommunicatingwithinternalsalesandmarketing colleagues• DevelopingSOPswithinyourdepartmenttosupporttranspar ency and compliance• Do’sanddon’tsofrespondingtorequestsforoff-licenceinformtion• Outliningthepotentialconsequencesofnoncompliance• AnticipatingthefutureofincreasedregulationthroughouttheEU
Vanessa Young, UK/ROI Medical Liaison Manager, LILLY, United Kingdom
Dr. Lincoln Tsang, Partner, ARNOLD & PORTER LLP; Nonexecutive Member, Regulatory Oversight Committee, HEALTH PROTECTION AGENCY; COUNCIL MEMBER, SCHOOL OF PHARMACY, UNIVERSITY OF LON-DON; Commissioner, BRITISH PHARMACOPOEIA COMMISSION, United Kingdom
10:30 30-MINUTE NETWORKING & REFRESHMENT BREAK
12:00 WORKSHOP CONCLUDES LUNCHEON FOR WORKSHOP PARTICIPANTS
MAIN CONFERENCE BEGINS · DAY ONE
13:00 Chairperson’s Welcome and Opening Remarks Dr. Alan Yong, Medical Affairs Manager Oncology, GLAXOSMITHKLINE, United Kingdom
13:15 · DEFINING AND EVALUATING THE ROLE OF THE MSL, MA and SA
Exploring Similarities and Differences in Job Titles, Descriptions and Daily Activities of Medical Science Liaisons, Medical Advisors, and Scientific Advisors across Companies and Countries• Whatnomenclatureismostprevalentandaccuratetodescribe field-based versus office-based medical affairs experts?• Outliningthecoreobjectivesofprofessionalsintheabovestated positions and how their activities differ• Whatdifferenteducationalbackgroundsaremostcommonly associated and necessary for each role?• Describingshort-termandlong-termgoalsandresponsibilities
Marc Van Melckenbeke, Senior Global Director Medical Communication & Coordination, Global Medical Affairs, UCB PHARMA, Belgium
Dr. David Harland, Medical Scientific Liaison, UCB PHARMA, United Kingdom
14:00 · INVESTIGATOR INITIATED TRIALS (IITs)
Outlining Best Practices for How MSLs and Advisors Can Best Support the Successful Execution of IITs across the EU• Providinginsightonstudyideasandprotocols• Assistingwiththeinternalapprovalprocessforinvestigatorswho propose study ideas• Helpingtoensureadherencetostudytimelinesandthemeeting of milestones• Fosteringtherelationshipbetweentheinvestigatorandthe sponsoring company
Dr. Sarah Peachey, Medical Manager, PFIZER, United Kingdom
14:45 NETWORKING AND REFRESHMENT BREAK
15:15 · BRAND DEVELOPMENT AND APPROVAL
Collaborating with Marketing and Sales to Foster Brand Strategy, Ensure Compliant Promotional Materials, and Achieve Corporate Objectives• Informingtheplanninganddevelopmentofbrandedmaterials• Reviewingpromotionalpiecesforclinicalcontentand compliance with relevant Codes of Practice and regulations before approving their print and distribution• Providingclearandmeaningfultrainingtointernalteamson scientific concepts related to company products• Ensuringtransparencyandqualityofcross-functionalexchanges for enhanced information sharing and ultimate achievement of business goals
Dr. Christian Felter, Director, FELTER CONSULTING LTD, United Kingdom
16:00 · KEY OPINION LEADER INITIATION AND DEVELOPMENT
Effectively Managing Relationships to Meet the Needs and Objectives of the KOL and the Company• DevelopingastrategyforinitiatingcontactwithanewKOL–how to establish credibility and rapport• Strengtheningcommunicationskillstohighlighttherapeuticarea expertise and support relationship building• DiscussingvariationsofKOLpreferencesforinformation exchange and how to accordingly tailor communication• Gatheringinsightsfromthefieldtoguidefuturebusinessdecisions
Dr. Dale Kummerle, Field Medical Strategy Lead, Virology, BRISTOL-MYERS SQUIBB, France
16:45
Roundtable Sessions with Attendees from the 3rd European Investigator-Initiated Trials Conference:1 Advisory Board Management: What are best practices for supporting, designing and delivering presentations at advisory boards?2 Resource Maximisation: How can teams eliminate waste and implement changes as budgets continue shrink?3 Small Company Challenges: How can MSLs and Advisors best manage unique challenges that coincide with working at a smaller company? 4 Team Management: What criteria should determine how MSLs/ Advisors are deployed and how can management support the goals of the individual team member, the department and the company?
Thursday, 28 October
11:00 · CORPORATE BUSINESS OBJECTIVES
Aligning the Activities and Goals of Field Based Teams for Strengthened Corporate Sustainability
• Examiningthedisconnectbetweenfieldbasedmedicaland corporate initiatives• Acquiringandsynthesizingfieldinsightstodriveclinicaland corporate decision-making• DemonstratingvalueoftheexpensiveMSLandAdvisorrolesto the company
Dr. Samuel Dyer, Former Senior Regional Medical Director, GENENTECH, United States
11:45 LUNCHEON
12:45 · CASE STUDY: FORMULARY DISCUSSIONS
Supporting Reimbursement Teams in Demonstrating Clinical Value to Payers• InvolvingMSLs/Advisorsearlyintheprocesstobestfacilitate formulary negotiations• Proactivelyprovidingscientificinformationtoeducatehealth care payers• Improvingcommunicationbetweeninternalteamsforstronger value demonstrations • Howistheroleofthehealthcarepayerchangingandistherea need for a dedicated sub-speciality of MSLs/Advisors?
Becky Reeve, Scientific Advisor Manager, Cardiovascular & Metabolism SAMs, SANOFI-AVENTIS, United Kingdom
13:30 · CAREER DEVELOPMENT
Identifying Different Opportunities Available to Individuals with MSL/Advisor Experience, Education Levels and Skills• Consideringdifferentpositionswithinthecompanyand industry that are aligned with the qualifications of MSLs and Advisors• Beingachampionofyourowngrowth• Engaginginpreceptorships,networkingeventsandshadowing activities to refine interests and learn more about different roles• Determiningwhentherighttimeistomakeachange
Dr. Chris Sugg, Senior Regional Medical Liaison, AMGEN GLOBAL ONCOLOGY SCIENTIFIC AFFAIRS, United States
14:15 · PANEL DISCUSSION
How Can Field-Based and Office-Based Medical Affairs Colleagues Best Support Each Other in their Roles?• WhatkindsoffieldinsightsarevaluableforMSLstobringback to SAs and MAs?• Howcanbrandinformationacquiredinternallybe communicated to field based medical to support their activities withKOLs?• Howcanteamsensuremeaningfulcollaborationtosupport corporate objectives?
Panelists:Dr. Drew Macgregor, EU Field Medical Operations Manager, EU Field Medical Centre of Excellence, BRISTOL-MYERS SQUIBB, FranceMarc Van Melckenbeke, Senior Global Director Medical Communication & Coordination, Global Medical Affairs, UCB PHARMA, Belgium
Interested in joining this panel discussion? Please contact Lindsay Slater at [email protected] for more information.
15:00 CLOSE OF CONFERENCE
5 Team Characteristics: What value do different educational degrees, professional background and skills bring and how should this impact recruitment decisions?6 Pharmacovigilance: How can MSLs/Advisors most effectively support drug safety?
17:45 CLOSE OF DAY ONE
MAIN CONFERENCE · DAY TWO
7:00 BREAKFAST FOR CONFERENCE PARTICIPANTS
8:00 Chairperson’s Recap of Day One and Moderators’ Key Points from Roundtable Discussions Dr. Alan Yong, Medical Affairs Manager Oncology, GLAXOSMITHKLINE, United Kingdom
8:15 · OFF-LICENCE INFORMATION
Compliantly Responding to Unsolicited Questions and Establishing Parameters for Off-Label Discussions• Definingwhat“off-licence”and“unsolicitedrequest”meanto your company• Discussingbenefitsversusriskstothefranchisewhen establishingSOPsforoff-licencerequests• Exploringstrategiesforhandlingrequeststhatphysiciansmake to sales • Determiningwhatinformationneedstobeincludedwhen documenting requests and conversations• Examiningtheregulationssurroundingoff-licenceinformation dissemination and considering the penalties and damage to the company of noncompliance
Dr. Nikki Church, Senior Medical Advisor, General Medicine, BAYER, United Kingdom
9:00 · COMPLIANCE AND TECHNOLOGY
Utilizing Technology to Increase Efficiency, Minimise Risk and Manage Compliance Requirements• Exploringstrategiesforhowtoeffectivelydocumentoff-licence information requests• Implementingasystemforenhancedmanagementandselection ofKOLs• Gatheringandsynthesizingfieldinsightsandinternal communications to benefit both field and office based colleagues
9:45 NETWORKING AND REFRESHMENT BREAK
10:15 · PERFORMANCE EVALUATION
Selecting Qualitative and Quantitative Metrics to Demonstrate the Value of the MSL or Advisor• Weighingthechallengesandbenefitsofqualitativeand quantitative metrics• Discussingspecificmetricsthathaveprovenresultsofeffectively assessing performance• Planningaheadforsuccessbysettingtargetsandagreeingon performance goals• Ensuringthatselectedmetricsarecompliantandnottiedtodirect sales generated for the company
Dr. Drew Macgregor, EU Field Medical Operations Manager, EU Field Medical Centre of Excellence, BRISTOL-MYERS SQUIBB, France
Conference Agenda
FIVe WAYS to ReGISteRFax: +1 212-400-9408Mail: ExL Events, Inc. 555 8th Ave, Ste 310 New York, NY 10018Phone: +1 212-400-6240Online: www.exlpharma.comEmail: [email protected]
EARLY BIRD PRICINGRegister by Friday, 17 September 2010 to Take Advantage of Early-Bird Pricing:Conference + Workshop £1,450ConferenceOnly £1,300
STANDARD PRICINGRegister After Friday, 17 September 2010: Conference + Workshop £1,600ConferenceOnly £1,450
ONSITE PRICINGConference + Workshop £1,750 ConferenceOnly £1,600
GRoUP DISCoUnt PRoGRAM: Save 25% per person when Registering Four For every three simultaneous registrations from your company, you will receive a fourth complimentary registration to the program (must register 4 at one time). This is a savings of 25% per person.
Save 15% per person when Registering Three Can only send three? You can still save 15% off of every registration. To find out more on how you can take advantage of these group discounts, please call + 1 212-400-6240.
Important! Discounts may not be combined. Discount only applies to standard rate. Make checks payable to ExL Events, Inc. and write code P1122 on your check. You may also use Visa, MasterCard, Discover or American Express. Payments must be received in full prior to the commencement of the conference.
Cancellations: If you need to cancel your registration for an upcoming ExL conference, please note the following policies derived from the Start Date of the event:Four weeks or more: A full refund (minus a $95 processing fee), or a voucher to another ExL event valid for two years from the voucher issue date. Four weeks or Less: A voucher to another ExL event valid for two years from the voucher issue date. To receive a refund or voucher, please fax your request to +1 212-400-9408.
Please Note: Conference registrations may be transferred to other colleagues in the event you are unable to attend. There will be an administrative charge of $300 to substitute, exchange and/or replace attendance badges with a colleague occurring within five business days of any ExL conference.
Please notify ExL Pharma, [email protected], prior to the event with the name and contact information of the replacement attendee.
Please Note: Speakers and agenda are subject to change without notice. In the event of a speaker cancellation, every effort to find a suitable replacement will be made.
*The opinions of this faculty do not necessarily reflect those of the companies they represent or ExL Events, Inc.*
Sponsorship and Exhibiting OpportunitiesDo you want to spread the word about your organisation’s solutions and services to potential clients who will be attending this event? Take advantage of the opportunity to exhibit, present an educational session, host a networking event, or distribute promotional items to attendees. ExL Pharma will work closely with you to customize a package that will suit all of your needs. To learn more about these opportunities, please contact:
Lucas Carrasco, business Development manager +1 212-400-6231, [email protected]
To Register call +1 212-400-6240 or visit us at www.exlpharma.com/euromsl
MeDIA PARtneRS
FEATURED SESSIONS INCLUDE:DEFIN
ING AN
D EVALUATING TH
E ROLE OF THE M
SL, MA AN
D SAE
xplorin
g Similarities an
d D
ifferences in
Job T
itles, Descrip
tions an
d
Daily A
ctivities of Med
ical Science Liaison
s, Med
ical Ad
visors, and
Scien
tific A
dvisors across C
omp
anies an
d C
oun
triesM
arc Van Melckenbeke, Senior Global Director Medical Communication & Coordination, Global
Medical Affairs, UCB PHARMA, BELGIUM
Dr. David Harland, Medical Scientific Liaison, UCB PHARM
A, United Kingdom
INVESTIGATOR IN
ITIATED TRIALS (IITs)O
utlin
ing B
est Practices for H
ow M
SLs and
Ad
visors Can
Best Su
pp
ort th
e Successfu
l Execu
tion of IITs across th
e EU
Dr. Sarah Peachey, Medical Manager, PFIZER, United Kingdom
KEY OPINION LEADER IN
ITIATION AND DEVELOPM
ENT
Effectively M
anagin
g Relation
ship
s to Meet th
e Need
s and
Ob
jectives of th
e KO
L and
the C
omp
any
Dr. Dale Kumm
erle, Field Medical Strategy Lead, Virology, BRISTOL-MYERS SQUIBB, France
The Only Event Led by, and D
esigned for, European Pharm
aceutical, Biotech and M
edical Device A
dvisors and MSLs!
Distinguished Speaking Faculty Joins Us From
:
AMGENARNOLD & PORTERBAYERBRISTOL-MYERS SQUIBBBRITISH PHARMACOPOEIA COMMISSIONFELTER CONSULTING LTDFORMER GENENTECHGLAXOSMITHKLINELILLYPFIZERSANOFI-AVENTISUCBAND M
ORE!
cAREER DEVELOPMEN
TId
entifyin
g Differen
t Op
portu
nities A
vailable to In
divid
uals w
ith
MSL/A
dvisor E
xperien
ce, Ed
ucation
Levels and
SkillsDr. Chris Sugg, Senior Regional Medical Liaison, AM
GEN GLOBAL ONCOLOGY SCIENTIFIC AFFAIRS, United States
To Register call +1 212-400-6240 or visit us at w
ww
.exlpharma.com
/euromsl
Bringing Maxim
um Value to the KOL,
Company and Industry
Medical/Scien
tific A
dvisor an
d Medical Scien
ce Liaison
Best P
racticesPROUDLY PRESENTS
28-29 OCTObER 2010, AmbASSADORS bLOOm
SbURy HOTEL, LONDON
REG
ISTER b
Y 17TH
SEPTEM
bER
FOR
RED
UcED
PR
IcING
Card Number Exp. Date:
Name on Card
Signature
TO R E G I S T E R
Yes! Register me for the Main Conference and Workshop
Corporate Rate: Main Conference
Corporate Rate: Plus Workshop
Please contact me: I’m interested in marketing opportunities at this event
I wish to receive email updates on ExL Pharma’s upcoming events
Name Title
Company
Dept.
Address
City State Zip
Telephone Fax
ExL Events, Inc.555 8th Avenue, Suite 310New York, NY 10018
888-221-6750866-207-6528
www.exlpharma.com
555 8th Avenue, Suite 310New York, NY 10018
PLEASE MENTION PRIORITY CODE: P1122
